Long-lived plasma cells, which produce autoantibodies in diseases such as systemic lupus erythematosus (SLE), are an as yet unexplored therapeutic target in such antibody-mediated disorders.
Researchers have developed a new microscopic method to observe the interactions of therapeutic antibodies with target molecules on tumor cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback